BiondVax Pharmaceuticals Ltd.
News
BiondVax Pharmaceuticals (NASDAQ:BVXV) & Sana Biotechnology (NASDAQ:SANA) Head to Head Review
Ticker Report BiondVax Pharmaceuticals (NASDAQ:BVXV Get Free Report) and Sana Biotechnology (NASDAQ:SANA Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, ...\n more…
BiondVax Pharmaceuticals (NASDAQ:BVXV) Coverage Initiated at StockNews.com
Ticker Report Investment analysts at StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV Get Free Report) in a research report issued on Friday. The firm set a...\n more…
BiondVax Pharmaceuticals (NASDAQ:BVXV) Coverage Initiated at StockNews.com
Zolmax StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV stock opened at $1.46 on Friday. BiondVax ...\n more…
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd.
Globe Newswire LOS ANGELES, July 11, 2023 (GLOBE NEWSWIRE) -- via IBN IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode ofThe Bell2Bell Podcast as part of its sustained effort to provide ...\n more…
BiondVax Pharmaceuticals (NASDAQ:BVXV) Receives New Coverage from Analysts at StockNews.com
Ticker Report StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV Free Report) in a research report released on Thursday. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance NASDAQ BVXV opened at $1.38 on Thursday. BiondVax Pharmaceuticals ...\n more…
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) Sees Significant Increase in Short Interest
Ticker Report BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV Free Report) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 53,800 shares, an increase of 232.1% from the May 31st total of 16,200 shares. Based on an average ...\n more…